Stephen Schultz, vice president of investor relations of GW Pharma basically just trash talked the entire US CBD industry.

“...maintained patients who suffer from severe forms of epilepsy need a drug that is consistent with the “hallmarks of a medicine." “And those hallmarks are that it doesn’t vary, it’s exactly the same every time the patient takes it, [and] that it’s fully described for how it performs both on the safety and efficacy standpoint against a placebo," he said, “so you know what it does and what it doesn’t do."

Most of the products marketed as CBD oils fail to carry such hallmarks, Schultz said, “and never will." In fact, he noted FDA tested several CBD products and discovered some didn’t even contain any cannabinoids.

“So now you have a very desperate patient population and companies … taking advantage of that," he said. “That’s a problem, and the FDA was established to protect the consumer, and that’s exactly what they’re doing."

In more obvious words Stephen is saying pretty much all US CBD products are unsafe and ineffective and the companies that make them are preying on desperately sick patients (as oppose to what not taking anything, continue to suffer and just wait for his drug to be approved? Sound reasoning there Stephen).

Using the guise of safety and lack of effectiveness (it's called 3rd party testing) the FDA should remove CBD from being sold otc in order to protect (his profits) you.